Coronavirus disease 2019 (COVID-19) arising from Wuhan, China, is currently outbreaking worldwide. The World Health Organization (WHO) has declared COVID-19 to be a global pandemic. COVID-19 could cause a wide range of symptoms ranging from self-limiting fever, sore throat, and cough to more severe symptoms that could lead to acute respiratory distress syndrome. As a result of the lockdown and increased demand, drug shortages could become a growing global issue. This article aims to shed light on the potential impact of drug shortages as a result of this pandemic on patient outcomes and the role of pharmacists and pharmacy policymakers in alleviating this emerging problem. Copyright © 2020. Published by Elsevier Inc.
Hisham A Badreldin, Bassam Atallah. Global drug shortages due to COVID-19: Impact on patient care and mitigation strategies. Research in social & administrative pharmacy : RSAP. 2021 Jan;17(1):1946-1949
PMID: 32446652
View Full Text